HumanInsight Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation
Harm Reduct J. 2022 Dec 3;19(1):132. doi: 10.1186/s12954-022-00718-1.
NO ABSTRACT
PMID:36463214 | DOI:10.1186/s12954-022-00718-1
Powered by WPeMatico
Sede Legale
Viale Campi Flegrei 55
80124 - Napoli
Sede Operativa
Via G.Porzio 4
Centro Direzionale G1
80143 - Napoli
